Director, Finance, Mid-Sized Markets
Revolution Medicines
| Company | Revolution Medicines |
| Category | Finance |
| Location | Basel |
| Remote | On-site (inferred) |
| Employment | Not stated |
| Level | Director |
| Salary | Not stated by the employer |
| Posted | 7 Aug 2026 |
| Last verified | 8 Aug 2026 |
| Source | Employer ATS (greenhouse) |
Description
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity
The Finance Director Europe Midsize Markets is the senior finance leader for the European Europe Midsize Markets Region (covering Switzerland, Austria, Netherlands, BeLux, the Nordics countries, Poland and the distributors’ markets), serving as the strategic business partner to the VP GM Europe Midsize Markets and their leadership team, and Country Managers while acting as the primary interface between the local business and the European Finance organization. The role ensures the successful delivery of finance operations through regional shared service teams and external partners, while providing financial leadership to the European Midsize Markets across planning, performance management, governance, statutory compliance, and business decision support. The Finance Director plays a critical role in enabling standardized finance processes across Europe while ensuring local business needs and regulatory requirements are effectively addressed.
Finance Leadership & Business Partnership
Serve as the primary finance representative and trusted advisor to the General Manager and the local Leadership Teams.
Partner with Commercial, Medical, Market Access, HR and other business functions to support strategic and operational decision-making.
Provide financial leadership to support commercial execution, launch readiness, resource allocation and investment decisions.
Evaluate business cases, contracts and strategic initiatives, providing objective financial recommendations.
Promote financial discipline and accountability across the Europe Midsize Markets.
Regional Finance Coordination
Act as the primary operational finance interface between the Europe Midsize Markets Region and the European Finance Shared Service organization.
Support the execution of transactional finance activities delivered centrally, including General Ledger, Procure to Pay, VAT, Payroll, Revenue Accounting, FP&A support and other finance operations.
Coordinate month-end close activities between local stakeholders and regional finance teams to ensure timely and accurate financial reporting.
Ensure efficient resolution of finance operational issues impacting the Europe Midsize Markets.
Build collaborative relationships with Corporate Finance, Shared Services and external service providers to ensure seamless finance operations.
Planning, Performance & Decision Support
Lead preparation of the annual budget (Revenue/Demand and expenses), re-forecasts, three-year operating plan and cash-flow forecasts.
Coordinate development and monitoring of the country Profit & Loss statement, operating expenses and headcount plans.
Challenge business assumptions and support scenario planning and financial modelling.
Monitor financial performance, KPIs, risks and opportunities, providing actionable recommendations to leadership.
Support business growth through robust financial analysis and performance management.
Revenue & Gross-to-Net
Partner with Commercial, Market Access and the Regional Revenue Accounting to develop and validate country gross-to-net assumptions.